Combination Chemotherapy in Patients With Advanced Urinary Tract Cancer

NCT00002684 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer
Urethral Cancer

Interventions

DRUG: cisplatin
DRUG: ifosfamide
DRUG: paclitaxel

Sponsor

Memorial Sloan Kettering Cancer Center